Ironwood Pharmaceuticals Inc banner

Ironwood Pharmaceuticals Inc
NASDAQ:IRWD

Watchlist Manager
Ironwood Pharmaceuticals Inc Logo
Ironwood Pharmaceuticals Inc
NASDAQ:IRWD
Watchlist
Price: 3.58 USD 0.28%
Market Cap: $582.4m

Wall Street
Price Targets

IRWD Price Targets Summary
Ironwood Pharmaceuticals Inc

Wall Street analysts forecast IRWD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IRWD is 4.95 USD with a low forecast of 0.71 USD and a high forecast of 8.4 USD.

Lowest
Price Target
0.71 USD
80% Downside
Average
Price Target
4.95 USD
38% Upside
Highest
Price Target
8.4 USD
135% Upside
Ironwood Pharmaceuticals Inc Competitors:
Price Targets
RLMD
Relmada Therapeutics Inc
93% Upside
GOSS
Gossamer Bio Inc
1 959% Upside
MASI
Masimo Corp
3% Upside
RYI
Ryerson Holding Corp
15% Upside

Revenue
Forecast

11% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
11% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

For the last 14 years the compound annual growth rate for Ironwood Pharmaceuticals Inc's revenue is 11%. The projected CAGR for the next 3 years is 7%.

Operating Income
Forecast

N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

The compound annual growth rate of Ironwood Pharmaceuticals Inc's operating income for the next 3 years is 19%.

Net Income
Forecast

N/A
Past Growth
80% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss
N/A
Past Growth
80% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss

The compound annual growth rate of Ironwood Pharmaceuticals Inc's net income for the next 3 years is 80%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IRWD's stock price target?
Price Target
4.95 USD

According to Wall Street analysts, the average 1-year price target for IRWD is 4.95 USD with a low forecast of 0.71 USD and a high forecast of 8.4 USD.

What is Ironwood Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
7%

For the last 14 years the compound annual growth rate for Ironwood Pharmaceuticals Inc's revenue is 11%. The projected CAGR for the next 3 years is 7%.

What is Ironwood Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
19%

The compound annual growth rate of Ironwood Pharmaceuticals Inc's operating income for the next 3 years is 19%.

What is Ironwood Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
80%

The compound annual growth rate of Ironwood Pharmaceuticals Inc's net income for the next 3 years is 80%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett